BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32389051)

  • 1. PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness.
    Raspollini MR; Montagnani I; Cirri P; Baroni G; Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Montironi R; Barnea ER
    Int J Biol Markers; 2020 Jun; 35(2):82-90. PubMed ID: 32389051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
    Diolombi ML; Epstein JI
    BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.
    Hoogland AM; Böttcher R; Verhoef E; Jenster G; van Leenders GJ
    Oncotarget; 2016 Jun; 7(25):37846-37856. PubMed ID: 27191985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preimplantation factor (PIF) promoting role in embryo implantation: increases endometrial integrin-α2β3, amphiregulin and epiregulin while reducing betacellulin expression via MAPK in decidua.
    Barnea ER; Kirk D; Paidas MJ
    Reprod Biol Endocrinol; 2012 Jul; 10():50. PubMed ID: 22788113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into PreImplantation Factor (PIF*) mechanism for embryo protection and development: target oxidative stress and protein misfolding (PDI and HSP) through essential RIKP [corrected] binding site.
    Barnea ER; Lubman DM; Liu YH; Absalon-Medina V; Hayrabedyan S; Todorova K; Gilbert RO; Guingab J; Barder TJ
    PLoS One; 2014; 9(7):e100263. PubMed ID: 24983882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
    Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
    Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preimplantation Factor (PIF) Promotes HLA-G, -E, -F, -C Expression in JEG-3 Choriocarcinoma Cells and Endogenous Progesterone Activity.
    Hakam MS; Miranda-Sayago JM; Hayrabedyan S; Todorova K; Spencer PS; Jabeen A; Barnea ER; Fernandez N
    Cell Physiol Biochem; 2017; 43(6):2277-2296. PubMed ID: 29073617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.
    Tosoian JJ; Druskin SC; Andreas D; Mullane P; Chappidi M; Joo S; Ghabili K; Agostino J; Macura KJ; Carter HB; Schaeffer EM; Partin AW; Sokoll LJ; Ross AE
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):228-233. PubMed ID: 28117387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.
    Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
    Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIN-like (Ductal) Adenocarcinoma of the Prostate.
    Paulk A; Giannico G; Epstein JI
    Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
    Li T; Huang S; Dong M; Gui Y; Wu D
    Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice.
    Weiss L; Bernstein S; Jones R; Amunugama R; Krizman D; Jebailey L; Almogi-Hazan O; Yekhtin Z; Shiner R; Reibstein I; Triche E; Slavin S; Or R; Barnea ER
    Endocrine; 2011 Aug; 40(1):41-54. PubMed ID: 21424847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Much Reliable Is the Current Belief on Grade Group 1 Prostate Cancer?
    Chung MS; Choi YJ; Lee YS; Yoon BI; Ha US
    Pathol Oncol Res; 2021; 27():629489. PubMed ID: 34257593
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune regulatory and neuroprotective properties of preimplantation factor: From newborn to adult.
    Barnea ER; Almogi-Hazan O; Or R; Mueller M; Ria F; Weiss L; Paidas MJ
    Pharmacol Ther; 2015 Dec; 156():10-25. PubMed ID: 26546485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PreImplantation Factor (PIF) correlates with early mammalian embryo development-bovine and murine models.
    Stamatkin CW; Roussev RG; Stout M; Absalon-Medina V; Ramu S; Goodman C; Coulam CB; Gilbert RO; Godke RA; Barnea ER
    Reprod Biol Endocrinol; 2011 May; 9():63. PubMed ID: 21569635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.